This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 2018 Jul 1;124(13):2674-2676.

doi: 10.1002/cncr.31371. Epub 2018 Apr 26.

Regimen of procarbazine, lomustine, and vincristine versus temozolomide for gliomas

Wolfgang Wick¹, Frank Winkler¹

Affiliations

Affiliation

¹ Neurology Clinic, University of Heidelberg; Clinical Cooperation Unit Neurooncology, German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany.

PMID: 29698549
DOI: 10.1002/cncr.31371

Free article

Comparative Study

Regimen of procarbazine, lomustine, and vincristine versus temozolomide for gliomas

Wolfgang Wick et al. Cancer. 2018.

Free article

. 2018 Jul 1;124(13):2674-2676.

doi: 10.1002/cncr.31371. Epub 2018 Apr 26.

Authors

Wolfgang Wick¹, Frank Winkler¹

Affiliation

¹ Neurology Clinic, University of Heidelberg; Clinical Cooperation Unit Neurooncology, German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany.

PMID: 29698549
DOI: 10.1002/cncr.31371

No abstract available

PubMed Disclaimer

Similar articles

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R, Rapp M, Meisner C, Kortmann RD, Pietsch T, Wiestler OD, Ernemann U, Bamberg M, Reifenberger G, von Deimling A, Weller M. Wick W, et al. J Clin Oncol. 2009 Dec 10;27(35):5874-80. doi: 10.1200/JCO.2009.23.6497. Epub 2009 Nov 9. J Clin Oncol. 2009. PMID: 19901110 Clinical Trial.
Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. [corrected].
DeAngelis LM. DeAngelis LM. J Clin Oncol. 2009 Dec 10;27(35):5861-2. doi: 10.1200/JCO.2009.24.5985. Epub 2009 Nov 9. J Clin Oncol. 2009. PMID: 19901101 No abstract available.
MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.
van den Bent MJ, Dubbink HJ, Sanson M, van der Lee-Haarloo CR, Hegi M, Jeuken JW, Ibdaih A, Brandes AA, Taphoorn MJ, Frenay M, Lacombe D, Gorlia T, Dinjens WN, Kros JM. van den Bent MJ, et al. J Clin Oncol. 2009 Dec 10;27(35):5881-6. doi: 10.1200/JCO.2009.24.1034. Epub 2009 Nov 9. J Clin Oncol. 2009. PMID: 19901104 Free PMC article. Clinical Trial.
Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV.
McDuff SGR, Dietrich J, Atkins KM, Oh KS, Loeffler JS, Shih HA. McDuff SGR, et al. Cancer Med. 2020 Jan;9(1):3-11. doi: 10.1002/cam4.2686. Epub 2019 Nov 7. Cancer Med. 2020. PMID: 31701682 Free PMC article. Review.
[Clinicopathological diagnosis of gliomas by genotype analysis].
Nakamura M, Shimada K, Nakase H, Konishi N. Nakamura M, et al. Brain Nerve. 2009 Jul;61(7):773-80. Brain Nerve. 2009. PMID: 19618854 Review. Japanese.

See all similar articles

Cited by

Accumulation of Temozolomide-Induced Apoptosis, Senescence and DNA Damage by Metronomic Dose Schedule: A Proof-of-Principle Study with Glioblastoma Cells.
Beltzig L, Stratenwerth B, Kaina B. Beltzig L, et al. Cancers (Basel). 2021 Dec 14;13(24):6287. doi: 10.3390/cancers13246287. Cancers (Basel). 2021. PMID: 34944906 Free PMC article.
Survival Analysis and Correlates with Molecular Epidemiology: 10-Year Retrospective Series of High-Grade Glioma in Pakistan.
Shah M, Anis SB, Yusuf I, Bajwa MH. Shah M, et al. J Cancer Allied Spec. 2024 Jan 22;10(1):565. doi: 10.37029/jcas.v10i1.565. eCollection 2024. J Cancer Allied Spec. 2024. PMID: 38259678 Free PMC article.
Therapeutic Options in Neuro-Oncology.
Afonso M, Brito MA. Afonso M, et al. Int J Mol Sci. 2022 May 11;23(10):5351. doi: 10.3390/ijms23105351. Int J Mol Sci. 2022. PMID: 35628161 Free PMC article. Review.
Clinical feasibility of modified procarbazine and lomustine chemotherapy without vincristine as a salvage treatment for recurrent adult glioma.
Ahn S, Kim YI, Shin JY, Park JS, Yoo C, Lee YS, Hong YK, Jeun SS, Yang SH. Ahn S, et al. Oncol Lett. 2022 Apr;23(4):114. doi: 10.3892/ol.2022.13234. Epub 2022 Feb 9. Oncol Lett. 2022. PMID: 35251345 Free PMC article.
Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells.
Beltzig L, Schwarzenbach C, Leukel P, Frauenknecht KBM, Sommer C, Tancredi A, Hegi ME, Christmann M, Kaina B. Beltzig L, et al. Cancers (Basel). 2022 Apr 29;14(9):2233. doi: 10.3390/cancers14092233. Cancers (Basel). 2022. PMID: 35565362 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program